Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
INDUSTRY
×
Biochemical Recurrence of Malignant Neoplasm of Prostate
×
Clear all
Filters
3
NCT05407311
2025-11-17
SABRE
Clarity Pharmaceuticals Ltd
Phase 2
Completed
53 enrolled
24 charts